Schedule 13D ownership disclosure
Lexicon Pharmaceuticals Inc
Security class unavailable · CUSIP: 528872302
Event date: 2018-06-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 36.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-209658
- Form type
- SC 13D
- Filer
- Invus, L.P.
- CIK
- CIK 1404570
- Filed
- Jun 29, 2018
- Reporting period
- Jun 27, 2018
- Description
- Schedule 13D beneficial ownership